REGENXBIO Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
REGENXBIO Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2015 to Q2 2024.
  • REGENXBIO Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $3.05M, a 191% increase year-over-year.
  • REGENXBIO Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $7.54M.
  • REGENXBIO Inc. annual Nonoperating Income (Expense) for 2023 was $4.48M.
  • REGENXBIO Inc. annual Nonoperating Income (Expense) for 2022 was -$17.5M, a 6.43% increase from 2021.
  • REGENXBIO Inc. annual Nonoperating Income (Expense) for 2021 was -$18.7M, a 242% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $7.54M $3.05M +$2M +191% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $5.53M $533K +$1.05M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $4.48M $862K +$3.07M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $1.41M $3.09M +$7.53M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$6.12M $1.05M +$6.69M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 -$12.8M -$519K +$4.72M +90.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$17.5M -$2.21M +$3.96M +64.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 -$21.5M -$4.44M -$3.38M -320% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$18.1M -$5.65M -$233K -4.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 -$17.9M -$5.24M +$856K +14% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 -$18.7M -$6.17M -$19.3M -147% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $590K -$1.06M +$4.11M +79.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$3.52M -$5.41M -$13M -171% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $9.47M -$6.09M -$3.76M -161% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $13.2M $13.2M +$1.68M +14.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $11.5M -$5.16M -$6.31M -550% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $17.8M $7.57M -$27.7M -78.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $45.6M -$2.34M -$5.95M -165% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $51.5M $11.5M +$7.99M +230% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $43.5M $1.15M -$1.08M -48.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $44.6M $35.3M +$27.2M +336% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $17.4M $3.61M +$1.39M +63% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $16M $3.48M +$2.88M +479% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $13.1M $2.23M +$1.63M +270% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $11.5M $8.09M +$7.51M +1288% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $4M $2.21M +$1.29M +138% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $2.72M $601K +$175K +41.1% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 $2.54M $603K +$89K +17.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $2.45M $583K +$68K +13.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $2.38M $929K +$446K +92.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $1.94M $426K Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $514K +$499K +3327% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $515K +$509K +8483% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $483K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q3 2015 $15K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $6K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.